TrialResults-center.org
Search
Menu
Home
Search
Recent trials
Browse pathology
Browse treatment
About us
new version V2017
Betrixaban
anticoagulant
Description
Results
PRT054021
Group by
Group by...
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in first
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in second
nothing
pathology
treatment
patient
comparator
classe
classe comparator
mechanism
in third
thrombosis prevention
Synopsis
Synopsis
Results
Treatments
Patients_
Method
References
Filters
Ongoing trials
Show ongoing trials
Hide ongoing trials
Risk of bias
Show all trials
Show only trial at low risk of bias
Hide exploratory trials
Conclusive result
Show all trials
Show only trial with conclusive result
All cause death
Coronary event
Adverse events
Bleeding
Cardiovascular death
Major bleeding
Minor bleeding
Haemmorhagic stroke
Fatal stroke
Non fatal stroke
Fatal bleeding
thrombo-embolic event (cerebral or systemic)
ischemic stroke
hypertransaminasemia
intracranial hemorrhage
TE event or ischemic stroke or systemic embolism
stroke (fatal and non fatal)
myocardial infarction (fatal and non fatal)
Symptomatic pulmonary embolism
Deep vein thrombosis
asymptomatic DVT
Venous thromboembolism
fatal pulmonary embolism
pulmonary embolism (symptomatic and asymptomatic)
Gastrointestinal major bleeding
Non-lifethreatening major bleeding
Lifethreatening major bleeding
Symptomatic deep-vein thrombosis
major or clinically relevant non-major bleeding
net benefit
Venous thromboembolism or death
proximal deep-vein thrombosis
systemic thrombo-embolic complication
pdf
Trial
Studied treatment
Control treatment
patients
ROB
Result
NCT
thrombosis prevention
APEX, 2016
betrixaban
enoxaparin
medical patients
Low risk of bias
Suggesting
NCT01583218
×
Modal title
